دورية أكاديمية

Removal of valproic acid by plasmapheresis in a patient treated for multiple sclerosis.

التفاصيل البيبلوغرافية
العنوان: Removal of valproic acid by plasmapheresis in a patient treated for multiple sclerosis.
المؤلفون: Bastiaans DE; Department of Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. d.bastiaans@akf.umcn.nl, van Uden IW, Ruiterkamp RA, de Jong BA
المصدر: Therapeutic drug monitoring [Ther Drug Monit] 2013 Feb; Vol. 35 (1), pp. 1-3.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7909660 Publication Model: Print Cited Medium: Internet ISSN: 1536-3694 (Electronic) Linking ISSN: 01634356 NLM ISO Abbreviation: Ther Drug Monit Subsets: MEDLINE
أسماء مطبوعة: Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: [New York] Raven Press.
مواضيع طبية MeSH: Multiple Sclerosis/*blood , Multiple Sclerosis/*therapy , Plasmapheresis/*methods , Valproic Acid/*blood , Valproic Acid/*therapeutic use, Anticonvulsants/blood ; Anticonvulsants/therapeutic use ; Drug Monitoring/methods ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/drug therapy
مستخلص: We present a case of a patient with multiple sclerosis who was treated with plasmapheresis and valproic acid. We used therapeutic drug monitoring to determine whether plasma concentrations of valproic acid were kept within the therapeutic window and to determine the amount of valproic acid that was removed by plasmapheresis.
المشرفين على المادة: 0 (Anticonvulsants)
614OI1Z5WI (Valproic Acid)
تواريخ الأحداث: Date Created: 20121211 Date Completed: 20130926 Latest Revision: 20131121
رمز التحديث: 20240628
DOI: 10.1097/FTD.0b013e31827b1cfa
PMID: 23222689
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-3694
DOI:10.1097/FTD.0b013e31827b1cfa